SAR438335
Total Payments
$18,716
Transactions
8
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $18,716 | 8 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,716 | 8 | 100.0% |
Top Doctors Receiving Payments for SAR438335
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Craig Pratt | — | Houston, TX | $11,336 | 1 |
| , MD | Clinical Cardiac Electrophysiology | Wynnewood, PA | $7,380 | 7 |
Ad
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $18,716
Product Information
- Type Drug
- Total Payments $18,716
- Total Doctors 2
- Transactions 8
About SAR438335
SAR438335 is a drug associated with $18,716 in payments to 2 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2017. In 2017, $18,716 was paid across 8 transactions to 2 doctors.
The most common payment nature for SAR438335 is "Consulting Fee" ($18,716, 100.0% of total).